• Latest Posts

Evotec and Bayer renew their vows and take on Kidney Disease

A €580M Collaboration for Endometriosis Therapies breaks into Clinical Development

Leading German Biotech Spins Off a New Startup in Autoimmune Diseases

Evotec enters Immuno-Oncology and Diabetes Therapy with Help from Sanofi

Biotech investors are back in Germany

ADVERTISEMENT